- $146.43bn
- $205.91bn
- $58.50bn
- 67
- 66
- 48
- 63
Pfizer Inc - Pfizers Sutent is Recommended as First-Line Treatment for Kidney C
AnnouncementPfizer Inc - Acquisition(s)
AnnouncementPfizer Inc - Pfizer Austrian Lipitor patent
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc Pfizer And Wyeth Become One: Working
AnnouncementPfizer Inc - Stephen W. Sanger Elected to Pfizers Board of Directors
AnnouncementPfizer Inc - Correction : UK Lipitor Patent
AnnouncementPfizer Inc - UK Lipitor Patent
AnnouncementPfizer Inc - Crystal Trial Confirms Central Role of Irinotecan in Metastatic Col
AnnouncementPfizer Inc. Study Shows Prevenar 13* Is Immunogenic In Young Children Previously
AnnouncementPfizer Inc - Lipitor decision
AnnouncementPfizer Inc - Pfizer Invites Public to Listen to Webcast of April 20 Conference C
AnnouncementPfizer Inc - EPA Honors Pfizer for Reducing Greenhouse Gas Emissions
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc - Pfizer reports progress with FDA on Viagra
AnnouncementPfizer Inc - Pfizer reaches agreement
AnnouncementPfizer Inc - Pfizer Announces Completion of $13.5 Billion Debt Offering
AnnouncementPfizer Inc Pfizer Announces Settlement And License Agreement With Mylan Related
AnnouncementPfizer Inc - Court in Denmark Upholds Two Lipitor Patents, Prevents Launch of Ra
Announcement